UK Chemotherapy Board Annual Conference 2020

As members of the UK Chemotherapy Board, we are delighted to announce that this year’s UK Chemotherapy Board Annual Conference will take place at the Pullman London St Pancras on Thursday 26th November 2020.

Please find attached draft agenda, we have a highly respected level of speakers who will provide thought provoking presentations.

To register your FREE place, please CLICK HERE

If you have a colleague who would be interested in attending, please forward this invitation.

We look forward to welcoming you at this year’s conference. For more information, please go to https://www.ukcbconference.co.uk/

Please see agenda: Agenda 2020

The BOPA Committee #BOPA #CHEMO2020

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article